| abstract |
MONOCLONAL ANTIBODY, HUMANIZED ANTIBODY, ANTIBODY FRAGMENT, USE OF AN ANTAGONIST, AND, HYBRIDOMA. The present invention relates to methods of treating pruritic diseases, including but not limited to Contact Dermatitis, Atopic Dermatitis, Drug-Induced Delayed Skin Allergic Reactions, Toxic Epidermal Necrolysis, Cutaneous T-Cell Lymphoma, Bullous Pemphigus, Alopecia wereata, Vitiligo, Acne Rosacea, Prurigo nodular, Scleroderma, Herpes simplex virus or a combination thereof by administering IL-3 monoclonal antibodies 1. The invention further provides hybridomas that generate monoclonal antibodies. |